#United States #New York #Securities Fraud #Semler Scientific #Pomerantz Law Firm

Pomerantz Law Firm Investigates Semler Scientific Inc.

Pomerantz LLP, a reputable law firm known for its expertise in securities class action litigation, has announced an investigation concerning Semler Scientific Inc. (NASDAQ: SMLR). This investigation follows alarming reports regarding potential securities fraud tied to the company and its executive team.

Background on the Investigation

The focus of Pomerantz's inquiry is whether Semler and certain officers or directors engaged in unlawful business practices that misled investors. According to the firm, affected investors are urged to reach out and discuss their circumstances. Danielle Peyton from Pomerantz is leading the communication effort, reachable via email and telephone.

This development comes in light of Semler's annual report for the fiscal year 2024, disclosed on February 28, 2025. In the report, Semler acknowledged a looming threat from the U.S. Department of Justice (DOJ), which hinted at possible legal action. The report explicitly stated the DOJ's intention to potentially file a complaint invoking the civil False Claims Act, which could result in substantial damages.

Additionally, in July 2017, Semler disclosed that it had received an initial civil investigative demand concerning claims for reimbursement tied to its QuantaFlo device, a product aimed at treating peripheral artery disease. This ongoing legal scrutiny has raised concerns about the company's transparency and operational ethics.

Market Reaction

The revelation of the DOJ's involvement triggered a significant drop in Semler's stock price. The shares plummeted by $4.03, marking a steep decline of 9.4%, with the stock closing at $38.89 on March 3, 2025. This decline resonated with investors, leading to fears regarding the company's future and its capability to recover from the legal challenges.

The Role of Pomerantz Law Firm

Pomerantz LLP, which has its roots dating back over 85 years, is highly respected for advocating the rights of victims who have suffered from corporate misconduct and securities fraud. The firm's founder, Abraham L. Pomerantz, is often referred to as the dean of the class action bar for his pivotal role in this domain. Pomerantz has represented clients in numerous high-stakes cases, consistently recovering substantial damages on behalf of investors.

The firm maintains an extensive network with offices in major cities including New York, Chicago, and London, enhancing its outreach and capability to assist affected investors. The commitment to holding companies accountable through corporate and securities litigation is a cornerstone of Pomerantz's operations.

How Affected Investors Can Respond

Investors concerned about their investments in Semler Scientific Inc. are encouraged to take prompt action. They can contact Danielle Peyton, using the provided contact details, to learn more about the investigation and potential legal recourse available to them. Participation in any ensuing class action may help them recoup losses incurred due to the alleged fraudulent activities tied to the company.

Conclusion

The investigation into Semler Scientific Inc. highlights the importance of transparency and accountability in corporate governance. As Pomerantz LLP delves deeper into the allegations of securities fraud, investors must stay informed and consider their options carefully. The outcome of this inquiry could have significant implications not only for the company but also for the broader market as investor confidence potentially wanes amidst such revelations.